Abbott Labs (ABT) PT Raised to $145 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Abbott Labs (ABT) PT Raised to $134 at Raymond James
October 21, 2021 7:21 AM EDTRaymond James analyst Jayson Bedford raised the price target on Abbott Labs (NYSE: ABT) to $134.00 (from $128.00) while maintaining a Outperform rating.... More
Abbott Labs (ABT) PT Raised to $141 at Citi
October 21, 2021 5:43 AM EDTCiti analyst Joanna Wuensch raised the price target on Abbott Labs (NYSE: ABT) to $141.00 (from $140.00) while maintaining a Buy rating.... More
Abbott Labs (ABT) PT Raised to $146 at Morgan Stanley
October 21, 2021 4:36 AM EDTMorgan Stanley analyst Cecilia Furlong raised the price target on Abbott Labs (NYSE: ABT) to $146.00 (from $136.00) while maintaining a Overweight rating.... More
Abbott Labs (ABT) PT Raised to $143 at BTIG, Following Earnings
October 20, 2021 2:27 PM EDTBTIG analyst Marie Thibault raised the price target on Abbott Labs (NYSE: ABT) to $143.00 (from $136.00) while maintaining a Buy rating.
... MoreAbbott raises annual earnings outlook as COVID-19 test sales rebound
October 20, 2021 7:36 AM EDTBy Mrinalika Roy and Carl O'Donnell
(Reuters) - Abbott Laboratories said demand for its COVID-19 tests, especially rapid testing, rebounded as the U.S. wrestled with surging coronavirus cases during the quarter, prompting the company to raise its earnings forecast for the year.
The medical device maker's shares rose 3.5% to $123.53 on Wednesday after it also reported third-quarter earnings above analysts' estimates.
The company said it shipped more than 225 million COVID-19 tests globally in... More
Abbott (ABT) Tops Q3 EPS by 47c, Sales Beat
October 20, 2021 7:32 AM EDTAbbott (NYSE: ABT) reported Q3 EPS of $1.40, $0.47 better than the analyst estimate of $0.93. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $9.44 billion.
GUIDANCE:
Abbott sees FY2021 EPS of $5.00-$5.10, versus the consensus of $4.45.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More